Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

NCT00104780 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: EP-2101
BIOLOGICAL: incomplete Freund's adjuvant

Sponsor

Epimmune